Kartikkumar Jinjuvadia, MD
Gastroenterology · Florence, KYNPI 1669678165
Payments from drug & device makers
Across 228 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$971
- Johnson & Johnson$306
- Sanofi$194
- Takeda Pharmaceuticals U.S.A., Inc.$186
- Boston Scientific$169
- plus $1K from 31 others
What the payments were for
- Consulting fees$341%
- Food & beverage$4,03597%
- Education$962%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 74 | $1,092 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 54 | $971 |
| Johnson & Johnson(2 entities) | 15 | $306 |
| Sanofi | 9 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $186 |
| Boston Scientific | 2 | $169 |
| QOL Medical, LLC | 6 | $136 |
| Dova Pharmaceuticals | 1 | $113 |
| Pfizer | 4 | $75 |
| Gilead | 3 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Ardelyx, Inc. | 3 | $54 |
| Braintree Laboratories, Inc. | 3 | $54 |
| Evoke Pharma, Inc. | 2 | $49 |
| Ironwood Pharmaceuticals, Inc | 3 | $49 |
| Intercept Pharmaceuticals, Inc. | 3 | $48 |
| Merck | 3 | $46 |
| Nestle Healthcare Nutrition Inc. | 3 | $45 |
| Amgen | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Bristol Myers Squibb | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Shionogi Inc | 2 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Mimedx Group, Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| GSK | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Olympus America Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$125
- DOPTELET$113
How this compares
$4,165 in reported general payments places this provider in the 50th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 68 | $47,619 |
| XifaxanRifaximin | 15 | $45,298 |
| CreonLipase/Protease/Amylase | 20 | $44,171 |
| RelistorMethylnaltrexone Bromide | 12 | $29,169 |
| TrulancePlecanatide | 14 | $10,647 |
| Mesalamine | 28 | $10,353 |
| MovantikNaloxegol Oxalate | 16 | $9,155 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 111 | $7,548 |
| Budesonide DrBudesonide | 34 | $5,017 |
| Pantoprazole Sodium | 368 | $4,496 |
| Ursodiol | 14 | $2,816 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 16 | $2,716 |
| Esomeprazole Magnesium | 50 | $1,801 |
| Sucralfate | 57 | $1,778 |
| Colestipol Hcl | 16 | $1,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $1,092 | $91,79088 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Relistor, Trulance | $971 | $85,11441 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $16 | $2,71616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 207 gastroenterology providers in Kentucky.
Other gastroenterology in Florence
- Michael HsuFlorence$10K
- Gerald DrydenLouisville$3.5M
- Michael JonesCrestview Hills$1.9M
- Jens RosenauLexington$1.6M
- Matthew CaveLouisville$916K
- Deborah FlomenhoftLexington$905K
- Michael KreaseLouisville$694K
- Zahid SaeedCrestview Hills$442K
- Thomas AbellLouisville$375K
- Sunana SohiLouisville$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.